Comparison of clinical characteristics of patients and occurrence of gammopathy or LPD
| Characteristic . | χ2test value for gammopathy (P) . | χ2test value for LPD (P) . |
|---|---|---|
| Age, y (≤ 46, > 46)* | 7.79 (.005) | 0.25 (.62) |
| CMV status of donor (+/−) | 0.69 (.41) | 1.71 (.19) |
| CMV status of recipient (+/−) | 0.01 (.94) | 1.19 (.27) |
| Sex (M/F) | 2.45 (.12) | 0.68 (.41) |
| CMV reactivation (+/−) | 0.36 (.55) | 0.63 (.43) |
| Acute graft rejection (+/−) | 4.22 (.04) | 0.04 (.85) |
| Viral cirrhosis (+/−) | 0.61 (.43) | 5.96 (.01) |
| HCV infection (+/−) | 1.39 (.24) | 1.10 (.29) |
| More than 1 transplantation (+/−) | 1.74 (.19) | 4.97 (.02) |
| Autoimmune disease (+/−) | 1.18 (.28) | 0.07 (.79) |
| Treatment | ||
| SAL (+/−) | 0.12 (.72) | 0.10 (.75) |
| OKT3 (+/−) | 1.23 (.27) | 0.02 (.87) |
| Characteristic . | χ2test value for gammopathy (P) . | χ2test value for LPD (P) . |
|---|---|---|
| Age, y (≤ 46, > 46)* | 7.79 (.005) | 0.25 (.62) |
| CMV status of donor (+/−) | 0.69 (.41) | 1.71 (.19) |
| CMV status of recipient (+/−) | 0.01 (.94) | 1.19 (.27) |
| Sex (M/F) | 2.45 (.12) | 0.68 (.41) |
| CMV reactivation (+/−) | 0.36 (.55) | 0.63 (.43) |
| Acute graft rejection (+/−) | 4.22 (.04) | 0.04 (.85) |
| Viral cirrhosis (+/−) | 0.61 (.43) | 5.96 (.01) |
| HCV infection (+/−) | 1.39 (.24) | 1.10 (.29) |
| More than 1 transplantation (+/−) | 1.74 (.19) | 4.97 (.02) |
| Autoimmune disease (+/−) | 1.18 (.28) | 0.07 (.79) |
| Treatment | ||
| SAL (+/−) | 0.12 (.72) | 0.10 (.75) |
| OKT3 (+/−) | 1.23 (.27) | 0.02 (.87) |
SAL indicates serum antilymphocyte preparations.
Median age of the 911 patients was 46 years.